Back to top

Pyxis Oncology (PYXS) Gets a Buy from H.C. Wainwright

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Pyxis Oncology, with a price target of $5.00. Th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Pyxis Oncology, Inc. (PYXS)